by Alex Watkins ONeill | Sep 2, 2025 | Content
Nearly 19 million children in the United States have at least one parent with a substance use disorder, according to a new study published in JAMA Pediatrics. And a significant number of those children have a parent whose addiction is moderate or severe as opposed to...
by Alex Watkins ONeill | Aug 19, 2025 | Content
As more adults over 65 develop chronic substance use problems, the landscape of available options, particularly for those who receive Medicare, is also rapidly changing. Deadly drug overdoses quadrupled for older adults between 2002 and 2021, but among Medicare...
by Amy Schussler | Aug 7, 2025 | Content
Expanding access to medication for opioid use disorder (MOUD), particularly long-acting injectable (LAI) buprenorphine, requires more than just willing and able pharmacists. These collaborations also require prescribers who understand their pivotal role in initiating...
by Alex Watkins ONeill | Aug 5, 2025 | Content
The talk of the town at this year’s American Society of Addiction Medicine annual conference was GLP-1 receptor agonists, generally known as medications to treat obesity. Mainstream media appears to mirror this trend as nearly every other radio and television ad...
by Amy Schussler | Aug 1, 2025 | Content
The Pharmacy Access to Resources and Medication for Opioid Use Disorder (PhARM-OUD) Guideline is a Joint Consensus Practice Guideline developed by the National Association of Boards of Pharmacy and the National Community Pharmacists Association. This comprehensive...
by Alex Watkins ONeill | Jul 29, 2025 | Content
The Food and Drug Administration is warning the public about the harmful effects of products containing tianeptine, also referred to as “gas station heroin” due to its availability in gas station stores. Tianeptine is an opioid alternative prescribed as an...
Recent Comments